You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelin-Binding Fluorophore

Showing 51 - 75 of 1,387
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Placenta Accreta Spectrum Pregnancies

Completed
  • Placenta Accreta, Third Trimester
  • Galectin 3
  • Konya, Turkey
    Necmettin Erbakan University Meram Medicine Faculty
Jul 6, 2023

NSCLC (NSCLC) Trial in Baltimore (ROSE (presence of cytotech), NO-ROSE (absence of cytotech))

Enrolling by invitation
  • Non-small Cell Lung Cancer (NSCLC)
  • ROSE (presence of cytotech)
  • NO-ROSE (absence of cytotech)
  • Baltimore, Maryland
  • +1 more
Jan 5, 2023

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting
  • Multiple Sclerosis (MS)
  • +6 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023

Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab

Completed
  • Multiple Sclerosis
    • East Hanover, New Jersey
      Novartis
    Jul 14, 2023

    Prostate Cancer, Bone Metastases Trial in Philadelphia ([68Ga]P15-041)

    Recruiting
    • Prostate Cancer
    • Bone Metastases
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Apr 29, 2022

    Healthy Trial in Örebro (Probiotic)

    Completed
    • Healthy
    • Probiotic
    • Örebro, Sweden
      Örebro University
    Jul 13, 2022

    Primary Soft-tissue Sarcoma Trial in Lebanon (ABY-029)

    Completed
    • Primary Soft-tissue Sarcoma
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Aug 25, 2021

    Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

    Recruiting
    • Advanced Breast Cancer
    • TQB3909 tablets
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Mar 16, 2023

    HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

    Recruiting
    • HIV-1-infection
    • INO-6160, 2 mg
    • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
    • New York, New York
    • +2 more
    Apr 13, 2023

    Rectal Cancer, Lung Cancer, Ovarian Cancer Trial in Changchun (Bevacizumab injection, Bevacizumab injection(Avastin))

    Completed
    • Rectal Cancer
    • +4 more
    • Bevacizumab injection
    • Bevacizumab injection（Avastin）
    • Changchun, Jilin, China
      Affiliated Hospital of Changchun University of Traditional Chine
    Jul 25, 2022

    Solid Tumors Trial in Copenhagen, Herlev (TB-403)

    Completed
    • Solid Tumors
    • TB-403
    • Copenhagen, Denmark
    • +1 more
    Mar 1, 2022

    Cannabis Use Disorder, Healthy Trial in New Haven ([11C]APP311)

    Recruiting
    • Cannabis Use Disorder
    • Healthy
    • New Haven, Connecticut
      Yale University School of Medicine
    Jul 20, 2022

    Cervical Spondylosis With Myelopathy, Degenerative Cervical Myelopathy Trial in Cambridge (3T MR Imaging of the cervical spinal

    Recruiting
    • Cervical Spondylosis With Myelopathy
    • Degenerative Cervical Myelopathy
    • 3T MR Imaging of the cervical spinal cord
    • +3 more
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospital
    May 26, 2022

    Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma Trial in Sacramento (18F-avß6-BP)

    Recruiting
    • Breast Carcinoma
    • +7 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jan 20, 2022

    Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)

    Recruiting
    • Advanced Malignant Tumor
    • TQB3915 tablets
    • Guangzhou, Guangdong, China
    • +2 more
    Jun 9, 2022

    Primary CNS Lymphoma Trial in Paris (PET-MRI)

    Not yet recruiting
    • Primary Central Nervous System Lymphoma
    • Paris, France
      Hôpital Pitié Salpêtrière
    May 20, 2022

    Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in

    Recruiting
    • Adult Primary Liver Cancer
    • +2 more
    • TSR-022 and TSR-042
    • Honolulu, Hawaii
      University of Hawaii
    Sep 22, 2021

    Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

    Active, not recruiting
    • Multiple Myeloma
    • Elranatamab (PF-06863135)
    • Beverly Hills, California
    • +75 more
    Oct 4, 2022

    Neurotoxicity in Gastrointestinal Cancer Patients Receiving

    Recruiting
    • Gastrointestinal Cancer
    • Folfox Protocol
    • Cairo, Abassia, Egypt
      Ain shams university
    Aug 8, 2022

    Fascin-1 in Colorectal Carcinoma

    Recruiting
    • Cancer of Colon
    • Immunohistochemistry
    • Sohag, Egypt
    • +1 more
    Oct 30, 2022

    Microglia in the Pathogenesis of Progressive Multiple Sclerosis

    Active, not recruiting
    • Multiple Sclerosis
      • Turku, Finland Proper, Finland
        Turku PET Centre
      Oct 12, 2022

      CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

      Recruiting
      • CML, Chronic Phase
      • CML, Accelerated Phase
      • HS-10382(Part 1: Dose escalation)
      • HS-10382(Part 2: Dose expansion)
      • Wuhan, Hubei, China
        Union Hospital affiliated to Tongji Medical College of Huazhong
      Jan 12, 2023

      Effects of Male-specific Antibodies on Sex Ratio

      Recruiting
      • Sperm Antibodies
      • Sex Ratio
      • Antibody-sperm binding
      • Odense, Denmark
        Fertility Clinic, Odense University Hospital
      May 25, 2022

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,

      Not yet recruiting
      • Acute Myeloid Leukemia, in Relapse
      • Acute Myeloid Leukemia Refractory
      • Cyclophosphamide (Non-IMP, Lymphodepletion)
      • +3 more
      • Ulm, Baden-Württemberg, Germany
      • +4 more
      Jul 24, 2023

      Immunoglobulin M-Anti-myelin-associated-glycoprotein(MAG)

      Recruiting
      • Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy
      • Clinical examination and patients' questionnaires regarding activity and participation (preliminary Immunogloblin M (IgM)-Rasch-built overall Disability Scale (RODS), and finalized IgM-RODS)
      • Bron, France
      • +1 more
      Mar 22, 2022